Colgate-Palmolive Company $CL Shares Acquired by Frank Rimerman Advisors LLC

Posted by Francis Steltz on Oct 18th, 2026

Frank Rimerman Advisors LLC lifted its holdings in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 49.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 29,912 shares of the company’s stock after buying an additional 9,958 shares during the period. Frank Rimerman Advisors LLC’s holdings in Colgate-Palmolive were worth $2,552,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. TD Capital Management LLC raised its stake in Colgate-Palmolive by 61.4% during the fourth quarter. TD Capital Management LLC now owns 326 shares of the company’s stock worth $26,000 after acquiring an additional 124 shares during the period. Virginia Estate & Retirement Planning Advisors Inc. lifted its holdings in Colgate-Palmolive by 1,409.1% in the third quarter. Virginia Estate & Retirement Planning Advisors Inc. now owns 332 shares of the company’s stock worth $28,000 after acquiring an additional 310 shares during the last quarter. Parvin Asset Management LLC acquired a new stake in shares of Colgate-Palmolive during the 2nd quarter worth approximately $32,000. Park Place Capital Corp raised its position in shares of Colgate-Palmolive by 55.5% during the 2nd quarter. Park Place Capital Corp now owns 356 shares of the company’s stock worth $33,000 after purchasing an additional 127 shares during the period. Finally, Gould Capital LLC raised its position in shares of Colgate-Palmolive by 38.7% during the 1st quarter. Gould Capital LLC now owns 412 shares of the company’s stock worth $35,000 after purchasing an additional 115 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 1.5%

Colgate-Palmolive stock opened at $94.02 on Friday. The company has a quick ratio of 0.67, a current ratio of 1.03 and a debt-to-equity ratio of 13.82. The firm has a 50-day moving average price of $89.05 and a two-hundred day moving average price of $89.02. The firm has a market capitalization of $74.95 billion, a price-to-earnings ratio of 37.31, a PEG ratio of 4.50 and a beta of 0.33. Colgate-Palmolive Company has a 52-week low of $74.54 and a 52-week high of $99.33.

Colgate-Palmolive (NYSE:CL – Get Free Report) last posted its earnings results on Friday, July 31st. The company reported $0.99 EPS for the quarter, topping the consensus estimate of $0.95 by $0.04. Colgate-Palmolive had a net margin of 9.68% and a return on equity of 464.63%. The firm had revenue of $5.36 billion during the quarter, compared to analysts’ expectations of $5.36 billion. During the same quarter in the prior year, the firm earned $0.92 EPS. Colgate-Palmolive’s quarterly revenue was up 4.9% on a year-over-year basis. Sell-side analysts expect that Colgate-Palmolive Company will post 3.87 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Tuesday, October 20th. Colgate-Palmolive’s payout ratio is 84.13%.

Insider Transactions at Colgate-Palmolive

In related news, Director John T. Cahill sold 4,170 shares of the stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the completion of the transaction, the director directly owned 28,373 shares of the company’s stock, valued at $2,649,187.01. This represents a 12.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Panagiotis Tsourapas sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The shares were sold at an average price of $92.05, for a total value of $920,500.00. Following the completion of the sale, the chief operating officer owned 64,901 shares in the company, valued at approximately $5,974,137.05. This represents a 13.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 175,191 shares of company stock worth $16,110,903. Company insiders own 0.43% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on CL shares. Sanford C. Bernstein reissued a “market perform” rating on shares of Colgate-Palmolive in a report on Thursday, August 13th. BNP Paribas Exane lowered their price objective on Colgate-Palmolive from $101.00 to $97.00 and set an “outperform” rating for the company in a research note on Monday, September 28th. Bank of America lowered their price objective on Colgate-Palmolive from $102.00 to $100.00 and set a “buy” rating for the company in a research note on Friday, October 9th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $104.00 target price on shares of Colgate-Palmolive in a research report on Tuesday, September 8th. Finally, Evercore raised their target price on Colgate-Palmolive from $100.00 to $101.00 and gave the company an “outperform” rating in a research note on Thursday, October 8th. Thirteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $97.95.

Read Our Latest Stock Analysis on Colgate-Palmolive

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.